Fueling an end to atherosclerosis

The support of our investors enables us to focus on the reversal of atherosclerosis and other serious conditions driven by excess cholesterol.

Investors

Investors

Emerging Longevity Ventures

Methuselah Foundation

LongevityTech.fund

Thynk Capital

Bioverge

SENS Research Foundation